Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion type Assertion NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_head.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion wasGeneratedBy ECO_0000203 NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_provenance.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion wasDerivedFrom befree-20150227 NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_provenance.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion SIO_000772 23435877 NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_provenance.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion evidence source_evidence_literature NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_provenance.
- NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_assertion description "[In NOD/SCID mice with subcutaneously inoculated HCC, sorafenib combined with S-1 yielded greater inhibition on tumor growth and remarkable TS suppression when compared with sorafenib or S-1 alone (all p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361237.RACDSriAm4WdwUflBtZJg8TitucJJiQVC8I56tFB-nDr0130_provenance.